Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
1.790
+0.030 (1.70%)
At close: Aug 14, 2026, 4:00 PM EDT
1.790
0.00 (0.01%)
After-hours: Aug 14, 2026, 7:59 PM EDT
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $230.33 million as of August 14, 2026. Its market cap has decreased by -63.02% in one year.
Market Cap
230.33M
Enterprise Value
251.18M
1-Year Change
-63.02%
Ranking
Category
Stock Price
$1.79
ChartMarket Cap Chart
Since January 8, 2019, Organogenesis Holdings's market cap has decreased from $1.24B to $230.33M, a decrease of -81.37%. That is a compound annual growth rate of -19.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 230.33M | -64.96% |
| Dec 31, 2025 | 657.40M | 63.40% |
| Dec 31, 2024 | 402.32M | -25.09% |
| Dec 29, 2023 | 537.07M | 52.51% |
| Dec 30, 2022 | 352.16M | -70.37% |
| Dec 31, 2021 | 1.19B | 23.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alpha Teknova | 396.22M |
| Anika Therapeutics | 283.32M |
| Aurora Cannabis | 245.20M |
| Akebia Therapeutics | 240.97M |
| Emergent BioSolutions | 230.22M |
| SIGA Technologies | 206.93M |
| Cardiol Therapeutics | 200.10M |
| Journey Medical | 183.10M |